BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 16751390)

  • 21. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mouse model for invariant NKT cell study.
    Wakao H; Kawamoto H; Sakata S; Inoue K; Ogura A; Wakao R; Oda A; Fujita H
    J Immunol; 2007 Sep; 179(6):3888-95. PubMed ID: 17785826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
    Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
    J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
    McCarthy C; Shepherd D; Fleire S; Stronge VS; Koch M; Illarionov PA; Bossi G; Salio M; Denkberg G; Reddington F; Tarlton A; Reddy BG; Schmidt RR; Reiter Y; Griffiths GM; van der Merwe PA; Besra GS; Jones EY; Batista FD; Cerundolo V
    J Exp Med; 2007 May; 204(5):1131-44. PubMed ID: 17485514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Gumperz JE
    Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
    Matsuda JL; Naidenko OV; Gapin L; Nakayama T; Taniguchi M; Wang CR; Koezuka Y; Kronenberg M
    J Exp Med; 2000 Sep; 192(5):741-54. PubMed ID: 10974039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.
    Matsuda JL; Gapin L; Fazilleau N; Warren K; Naidenko OV; Kronenberg M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12636-41. PubMed ID: 11592984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
    Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
    Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
    Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
    PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
    Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
    Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKT TCR recognition of CD1d-α-C-galactosylceramide.
    Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
    J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.
    Giabbai B; Sidobre S; Crispin MD; Sanchez-Ruìz Y; Bachi A; Kronenberg M; Wilson IA; Degano M
    J Immunol; 2005 Jul; 175(2):977-84. PubMed ID: 16002697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.